UPC APP 24411/2025

—·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Vergleichshomologation
Parteien: Kläger
Tandem Diabetes Care Europe B.V.
Tandem Diabetes Care, Inc.
Vertreter: Christian Dekoninck (Taylor Wessing); null (AOMB)
Beklagte
Roche Diabetes Care GmbH
Vertreter: Christof Augenstein (Kather Augenstein); null (Grünecker Patent- und Rechtsanwälte PartGmbH)
Division: Court of Appeal
Richter: Rian Kalden · Presiding judge and legally qualified judge
Ingeborg Simonsson · Legally qualified judge and judge-rapporteur
Patricia Rombach · Legally qualified judge
Jeroen Meewisse · Technically qualified judge
Stefan Wilhelm · Technically qualified judge
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 5. Juni 2025

Entscheidungen

2025-06-05
VergleichApplication Rop 365
The Court of Appeal confirmed a settlement agreement between Tandem Diabetes and Roche Diabetes, terminating the appeal proceedings. The settlement arose after the Central Division Paris had dismissed the revocation action and maintained EP 2 196 231 as granted.
Rechtsfragen:Settlement confirmationR.365 RoPRevocation actionAmbulatory drug infusion system

Dokumente